Mactier R A, Khanna R, Twardowski Z, Moore H, Nolph K D
Department of Medicine, University of Missouri Health Sciences Center, Columbia 65212.
J Clin Invest. 1987 Nov;80(5):1311-6. doi: 10.1172/JCI113207.
The contribution of peritoneal cavity lymphatic absorption to ultrafiltration kinetics and solute clearances in continuous ambulatory peritoneal dialysis was evaluated in patients with normal (group 1) and high (group 2) peritoneal permeability X area during 4-h exchanges using 2 liters 2.5% dextrose dialysis solution with 30 g added albumin. Cumulative lymphatic drainage in all continuous ambulatory peritoneal dialysis (CAPD) patients averaged 358 +/- 47 ml per 4-h exchange and reduced cumulative net transcapillary ultrafiltration at the end of the exchange by 58 +/- 7.2%. The peak ultrafiltration volume was observed before osmotic equilibrium between serum and dialysate was reached and occurred when the net transcapillary ultrafiltration rate had decreased to equal the lymphatic absorption rate. Thereafter the lymphatic absorption rate exceeded the net transcapillary ultrafiltration rate, and intraperitoneal volume decreased. Extrapolated to 4 X 2 liters, 2.5% dextrose, 6-h exchanges per d, lymphatic drainage reduced potential daily net ultrafiltration by 83.2 +/- 10.2%, daily urea clearance by 16.9 +/- 1.9%, and daily creatinine clearance by 16.5 +/- 1.9%. Although lymphatic absorption did not differ between the two groups, lymphatic drainage caused a proportionately greater reduction in net ultrafiltration in group 2 (P less than 0.025), because these patients had more rapid dialysate glucose absorption (P less than 0.05) and less cumulative transcapillary ultrafiltration (P less than 0.01). These findings indicate that cumulative lymphatic drainage significantly reduces net ultrafiltration and solute clearances in CAPD and that ultrafiltration failure in CAPD occurs when daily lymphatic absorption equals or exceeds daily transcapillary ultrafiltration. Reduction of lymphatic absorption may provide a means for future improvement in the efficiency of CAPD.
在使用添加了30克白蛋白的2升2.5%葡萄糖透析液进行4小时交换的过程中,对正常腹膜通透性X面积(第1组)和高腹膜通透性X面积(第2组)的患者评估了腹腔淋巴吸收对持续非卧床腹膜透析中超滤动力学和溶质清除率的影响。所有持续非卧床腹膜透析(CAPD)患者每4小时交换的累积淋巴引流平均为358±47毫升,交换结束时累积净跨毛细血管超滤减少了58±7.2%。超滤峰值出现在血清和透析液达到渗透平衡之前,当净跨毛细血管超滤率降至等于淋巴吸收率时出现。此后,淋巴吸收率超过净跨毛细血管超滤率,腹腔内体积减小。推算至每天4×2升2.5%葡萄糖、6小时交换,淋巴引流使每日潜在净超滤减少83.2±10.2%,每日尿素清除率减少16.9±1.9%,每日肌酐清除率减少16.5±1.9%。尽管两组之间的淋巴吸收没有差异,但淋巴引流在第2组中导致净超滤的减少比例更大(P<0.025),因为这些患者的透析液葡萄糖吸收更快(P<0.05)且累积跨毛细血管超滤更少(P<0.01)。这些发现表明,累积淋巴引流显著降低了CAPD中的净超滤和溶质清除率,并且当每日淋巴吸收等于或超过每日跨毛细血管超滤时,CAPD中会出现超滤失败。减少淋巴吸收可能为未来提高CAPD的效率提供一种方法。